Mostrar el registro sencillo del ítem

Keratoconus: a review and possible epidemiological situation in Colombia.

dc.creatorMora Valencia, Matilde
dc.creatorBonilla Estévez, Claudia
dc.creatorVargas Garzón, Oswaldo
dc.creatorGiraldo Valencia, Olga Lucía
dc.date2007-12-15
dc.date.accessioned2019-11-08T21:25:10Z
dc.date.available2019-11-08T21:25:10Z
dc.identifierhttp://hemeroteca.unad.edu.co/index.php/nova/article/view/388
dc.identifier10.22490/24629448.388
dc.identifier.urihttps://repository.unad.edu.co/handle/10596/30089
dc.descriptionIn Colombia and throughout the world we know how to define keratoconus. We diagnose it with an excellent precision, usually without the aid of the corneal topography. With a test of queratometría, the professionals of the visual and ocular health can observe inductive nonclear sights of keratoconus that is a corneal degeneration of idiopatic cause. To say that its origin is hereditary, can be as false as to say that its origin is metabolic. What do we know for sure? Much and nothing at all. The only truth is that while in other countries its incidence and prevalence is well-known, in Colombia we do not have registered data officially. The registry is subclinical, because although it exists between the international classifications of the diseases, version 10, as clinical pathology, the professionals of the visual health and ocular normally do not register it. The objective of this article is to present a general revision of this pathology.en-US
dc.descriptionEn Colombia y en el mundo entero sabemos cómo definir el queratocono, lo diagnosticamos con una excelente propiedad, incluso muchas veces, aún sin ayuda de la topografía corneal, con una prueba de queratometría, los profesionales de la salud visual y ocular podemos observar miras no nítidas inductoras de queratocono. Es una degeneración corneal de causa idiopática. Decir que su origen es hereditario, puede ser tan falso como decir que su origen es metabólico. ¿Que sabemos a ciencia cierta? mucho y nada, pero la única realidad es que mientras en otros países su incidencia y prevalencia es conocida, en Colombia no tenemos datos registrados oficialmente. El registro es subclínico, pues aunque existe entre la clasificación internacional de las enfermedades, versión 10, como patología clínica, los profesionales de la salud visual y ocular normalmente no lo registran. El objetivo de este artículo es presentar una revisión general de esta patología.es-ES
dc.formatapplication/pdf
dc.languagespa
dc.publisherUniversidad Colegio Mayor de Cundinamarcaes-ES
dc.relationhttp://hemeroteca.unad.edu.co/index.php/nova/article/view/388/1169
dc.relation/*ref*/Velarde J. Queratocono Subclínico en paciente portador de lentes de contacto, candidato a cirugía refractiva, 20 meses de seguimiento topográfico. Rev Española de contactología. 2000;10: http://www.oftalmo.com/sec/00-tomo-1/08.htm 2. Cadena D. Manual de Anatomia Humana. Tercera Edición, Celsus 1992, p 344-345. 3. Arffa R. Enfermedad de la Córnea. 4ta ed. España: Brace Publishers International. 1999; p1-19. 4. Lebow KA, Grohe RM. Differentiating contact lens induced war page from true keratoconus using corneal topography. CLAO J 1999;25:114-122. 5. Barraquer R, De Toledo M, Torres E. Distrofias y degeneraciones corneales. Barcelona: España; 2004; p13. 6. Abad J, Awad A, Kurstin J. Hyperopic keratoconus. J Refract Surg. 2007;23:520-523. 7. Díaz G, Caíñas A, Jiménez C, Neira P. Características epidemiológicas en pacientes portadores de queratocono Rev Cubana Oftalmol 1999;12:20-26. 8. Carmi E, Defossez-Tribout C, Ganry O, Cene S, Tramier B, Milazzo S, Lok C.Acta Derm Ocular complications of atopic dermatitis in children. Venereol. 2006;86:515-517. 9. Kuo IC, Broman A, Pirouzmanesh A, Melia M Is there an association between diabetes and keratoconus? Ophthalmology. 2006;113:184-190. 10. Lema I, Durán J. Inflammatory molecules in the tears of patients with keratoconus. Ophthalmology. 2005;112:654-659. 11. Byström B, Virtanen I, Rousselle P, Miyazaki K, Lindén C, Pedrosa Domellöf F. Laminins in normal, keratoconus, bullous keratopathy and scarred human corneas Histochem Cell Biol. 2007;127:657-667. 12. Kenney MC, Chwa M, Atilano SR, Tran A, Carballo M, Saghizadeh M, Vasiliou V, Adachi W, Brown DJ Increased levels of catalase and cathepsin V/L2 but decreased TIMP-1 in keratoconus corneas: evidence that oxidative stress plays a role in this disorder Invest Ophthalmol Vis Sci. 2005;46:823-832. 13. Dellambra E, Patrone M, Sparatore B, Negri A, Ceciliani F, Bondanza S, Molina F, Cancedda FD, De Luca M. Stratifin, a keratinocyte specific 14-3-3 protein, harbors a pleckstrin homology (PH) domain and enhances protein kinase C activity. J Cell Sci. 1995;108:3569-3579. 14. Zanello SB, Nayak R, Zanello LP, Farthing-Nayak P. Identification and distribution of 14.3.3sigma (stratifin) in the human cornea. Curr Eye Res. 2006;10:825-833. 15. Rosas E. Queratocono. Franja Visual. 1991;3:15-17. 16. De La Torre A. PRK y LASEK en sospechosos de queratocono. Colom Med. 2004;35:46-49. 17. Simo Mannion L, Tromans C, O’Donnell C. An evaluation of corneal nerve morphology and function in moderate keratoconus Cont Lens Anterior Eye. 2005 ;28:185-192. 18. Rohrbach JM, Szurman P, El-Wardani M, Grüb M. About the frequency of excessive epithelial basement membrane thickening in keratoconusKlin Monatsbl Augenheilkd. 2006;223:889-893. 19. Brookes N, Loh I, Clover G, Poole C, Sherwin T. Involvement of corneal nerves in the progression of keratoconus. Exp Eye Res.2003;77:515-24. 20. Teng SW, Tan HY, Peng JL, Lin HH, Kim KH, Lo W, Sun Y, Lin WC, Lin SJ, Jee SH, So PT, Dong CY. Multiphoton autofluorescence and second-harmonic generation imaging of the ex vivo porcine eye. Invest Ophthalmol Vis Sci. 2006;47:1216-1224. 21. Morishige N, Wahlert AJ, Kenney MC, Brown DJ, Kawamoto K, Chikama T, Nishida T, Jester JV. Second-harmonic imaging microscopy of normal human and keratoconus cornea. Invest Ophthalmol Vis Sci. 2007;48:1087-1094. 22. Whitelock RB, Fukuchi T, Zhou L, Twining SS, Sugar J, Feder RS, Yue BY. Cathepsin G, acid phosphatase, and alpha 1-proteinase inhibitor messenger RNA levels in keratoconus corneas. Invest Ophthalmol Vis Sci. 1997;38:529-534. 23. Matthews FJ, Cook SD, Majid MA, Dick AD, Smith VA. Changes in the balance of the tissue inhibitor of matrix metalloproteinases (TIMPs)-1 and -3 may promote keratocyte apoptosis in keratoconus. Exp Eye Res. 2007;84:1125-1134. 24. Nielsen K, Birkenkamp-Demtröder K, Ehlers N, Orntoft TF. Identification of differentially expressed genes in keratoconus epithelium analyzed on microarrays. Invest Ophthalmol Vis Sci. 2003;44:2466-2476. 25. Hughes AE, Dash DP, Jackson AJ, Frazer DG, Silvestri G. Familial keratoconus with cataract: linkage to the long arm of chromosome 15 and exclusion of candidate genes. Invest Ophthalmol Vis Sci. 200;44:5063 5066. 26. Tyynismaa H, Sistonen P, Tuupanen S, Tervo T, Dammert A, Latvala T, Alitalo T. A locus for autosomal dominant keratoconus: linkage to 16q22.3-q23.1 in Finnish families. Invest Ophthalmol Vis Sci. 2002;43:3160-3164. 27. Thalasselis A. The possible relationship between keratoconus and magnesium deficiency. Ophthalmic Physiol Opt. 2005;25:7-12. 28. Lipman RM, Rubenstein JB, Torczynski E. Keratoconus and Fuchs’ endothelial dystrophy. Cornea. 1991;10:368. 29. Bergmanson JP, Sheldon TM, Goosey JD. Fuchs’ endothelial dystrophy: a fresh look at an aging disease. Ophthalmic Physiol Opt. 1999;19:210-222. 30. Ventocilla M, Stamler J. Contact Lens Complications. www.emedicine.com. 2006. 31. Maeda N, Klyce SD, Smolek MK, Thompson HW. Automated keratoconus screening with corneal topography analysis. InvestOphthalmol Vis Sci. 1994;35:2749-2757. 32. Rabinowitz YS. Intacs for keratoconus. Curr Opin Ophthalmol. 2007;18:279-283. 33. Avendaño J, Rodríguez E. «La Agudeza Visual en Colombia, ENS Instituto Nacional de Salud. 1981. 34. Wahrendorf I. How to live with keratoconus. Klin Monatsbl Augenheilkd. 2006;223:877-888. 35. Yepez A. Salud visual en población menor de 15 años. Programa de atención primaria en Salud Antioquia, Colombia. Ia Treia. 1989; 2:201-206. 36. Arntz A, Durán JA, Pijoán JI. Subclinical keratoconus diagnosis by elevation topography Arch Soc Esp Oftalmol. 2003;78:659-664. 37. Levy D, Hutchings H, Rouland JF, Guell J, Burillon C, Arné JL, Colin J, Laroche L, Montard M, Delbosc B, Aptel I, Ginisty H, Grandjean H, Malecaze F. Videokeratographic anomalies in familial keratoconus. Ophthalmology. 2004;111:867-874. 38. Abad JC, Rubinfeld RS, Del Valle M, Belin MW, Kurstin JM Vertical D: a novel topographic pattern in some keratoconus suspects. Ophthalmology. 2007;114:1020-1026. 39. Rosas E. Médico cirujano Oftalmólogo. Franja Visual, 1991;3:15-17. 40. Charter L. Ophthalmology Times, Cleveland,2006;31:51-52. 41. McMahon TT, Szczotka-Flynn L, Barr JT, Anderson RJ, Slaughter ME, Lass JH, Iyengar SK; CLEK Study Group. A new method for grading the severity of keratoconus: the Keratoconus Severity Score (KSS).Cornea. 2006;25:794-800. 42. Luz A, Ursulio M, Castañeda D, Ambrósio R Jr. Corneal thickness progression from the thinnest point to the limbus: study based on a normal and a keratoconus population to create reference values.Arq Bras Oftalmol. 2006;69:579-583. 43. Bühren J, Kühne C, Kohnen T. Defining subclinical keratoconus using corneal first-surface higher-order aberrations. Am J Ophthalmol. 2007;143:381-389. 44. Jain AK, Sukhija J. Rose-K contact lens for keratoconus Indian J Ophthalmol. 2007;55:121-125. 45. Hernández P. Reinventando las lentes semiesclerales. Gaceta óptica,2006;402:20-25. 46. González-Pérez J, Arrojo N, Parafita MA. Adaptación de LC asférica de alta excentricidad modificada en queratocono unilateral. Rev. Esp. Contact. 2005;12:69-73. 47. Seiler T, Hafezi F. Corneal cross-linking-induced stromal demarcation line Cornea. 2006;25:1057-1059. 48. Mazzotta C, Traversi C, Baiocchi S, Sergio P, Caporossi T, Caporossi A. Conservative treatment of keratoconus by riboflavin-uva-induced cross-linking of corneal collagen: qualitative investigation. Eur J Ophthalmol. 2006;16:530-535. 49. Guttman Ch. Ophthalmology Times, Cleveland, vol 32 ISS 7 pag 40-41 (2pp). 2007. 50. Levinger S, Pokroy R. Keratoconus managed with intacs: oneyear results. Arch Ophthalmol. 2005;123:1308-1314. 51. Charter, Lynda. Ophthalmology Times, Cleveland, vol 32 ISS 4 pag 42-43 (2pp).2007. 52. Unal M, Yücel I, Akar Y, Akkoyunlu G, Ustünel I. Recurrence of keratoconus in two corneal grafts after penetrating keratoplasty Cornea. 2007;26:362-364. 53. Ezra DG, Mehta JS, Allan BD. Late corneal hydrops after penetrating keratoplasty for keratoconus. Cornea. 2007;26(5):639-640. 54. Científicos del Colegio Médico Jeferson, Universidad ThomasJefferson. Health and Medicine Week. Atlanta, pag 243. 2007
dc.rightsCopyright (c) 2007 NOVA Publicación en Ciencias Biomédicases-ES
dc.rightshttp://creativecommons.org/licenses/by/4.0es-ES
dc.sourceNOVA Biomedical Sciences Journal; Vol. 5, Núm. 8 (2007); 185-196en-US
dc.sourceNova; Vol. 5, Núm. 8 (2007); 185-196es-ES
dc.sourceNOVA Ciências Biomédicas Publicação; Vol. 5, Núm. 8 (2007); 185-196pt-BR
dc.source2462-9448
dc.source1794-2470
dc.subjectblepharitis; cornea; keratoconus; metabolic disorder; corneal topography; tachymetry.en-US
dc.subjectblefaritis; córnea; hipermetropía; queratocono; taquimetría; topografía corneal.es-ES
dc.titleKeratoconus: a review and possible epidemiological situation in Colombia.en-US
dc.titleQueratocono: una revisión y posible situación epidemiológica en Colombia.es-ES
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typereviewArticleen-US
dc.typereviewArticlees-ES
dc.typereviewArticlept-BR


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem